Literature DB >> 28631309

Obstructive sleep apnea and silent cerebral infarction in hypertensive individuals.

José Alvarez-Sabín1, Odile Romero2,3, Pilar Delgado4, Manuel Quintana1, Estevo Santamarina1, Alex Ferré2, Olga Maisterra1, Iolanda Riba-Llena4, Joan Montaner4, Gabriel Sampol3,5.   

Abstract

Obstructive sleep apnea syndrome is very prevalent in hypertensive subjects. Moreover, obstructive sleep apnea syndrome activates multiple processes that might be associated with silent cerebral infarct independently of established risk factors. Our aim is to estimate the frequency of obstructive sleep apnea syndrome in hypertensive patients with and without silent cerebral infarct, and to determine whether obstructive sleep apnea syndrome is an independent risk factor of silent cerebral infarct and/or lacunar silent cerebral infarct in patients with hypertension. In this matched cross-sectional study performed in hypertensive subjects, each patient with silent cerebral infarct detected by magnetic resonance imaging was matched with two patients without silent cerebral infarct. Polysomnographic studies were performed, and the apnea-hypopnea index was calculated. Severe obstructive sleep apnea syndrome was considered in those with apnea-hypopnea index >30. One-hundred and eighty-three patients, 61 with silent cerebral infarct and 122 without silent cerebral infarct, were evaluated. The mean age was 64.1 ± 4.5 years, and 72.1% were men. The frequency of severe obstructive sleep apnea syndrome was 44.3% in patients with silent cerebral infarct and 38.5% in the control group. An adjusted conditional logistic regression model did not show a significant increased risk of silent cerebral infarct in patients with severe obstructive sleep apnea syndrome (odds ratio 1.362; 95% confidence interval: 0.659-2.813; P = 0.404). Forty-three patients (70.5%) of the silent cerebral infarct were lacunar. The presence of severe obstructive sleep apnea syndrome was significantly higher in lacunar silent cerebral infarct when compared with patients without lacunar infarcts (55.8% versus 35.7%, P = 0.019), being independently associated on an adjusted logistic regression model (odds ratio 2.177; 95% confidence interval: 1.058-4.479; P = 0.035). In conclusion, severe obstructive sleep apnea syndrome is highly prevalent among hypertensive subjects, and is independently associated with lacunar silent cerebral infarct.
© 2017 European Sleep Research Society.

Entities:  

Keywords:  lacunar infarction; respiratory events; stroke

Mesh:

Year:  2017        PMID: 28631309     DOI: 10.1111/jsr.12571

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  5 in total

1.  Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension.

Authors:  Iolanda Riba-Llena; José Álvarez-Sabin; Odile Romero; Estevo Santamarina; Gabriel Sampol; Olga Maisterra; Álex Ferré; Joan Montaner; Manuel Quintana; Pilar Delgado
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

2.  Correlation between coronary artery disease and obstructive sleep apnea syndrome and analysis of risk factors.

Authors:  Jidong Zhang; Yu Song; Yang Ji; Yiying Song; Shanglang Cai; Yanling Yu; Song Liu; Wenzhong Zhang
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 3.  Obstructive Sleep Apnea and Cardiovascular Morbidities: A Review Article.

Authors:  Dibyata Rana; Chenet Torrilus; Wiqas Ahmad; Nkechi A Okam; Tehreem Fatima; Nusrat Jahan
Journal:  Cureus       Date:  2020-09-13

Review 4.  Association and Risk Factors for Obstructive Sleep Apnea and Cardiovascular Diseases: A Systematic Review.

Authors:  Amal K Mitra; Azad R Bhuiyan; Elizabeth A Jones
Journal:  Diseases       Date:  2021-12-02

5.  Mechanical thrombectomy for a 12-year-old boy with acute ischemic stroke: A case report.

Authors:  Yuchai Huang; Zhen Wang; Changluo Li; Ning Ding
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.